tradingkey.logo

Myomo Inc

MYO
0.928USD
+0.027+3.05%
收盤 12/19, 16:00美東報價延遲15分鐘
35.69M總市值
虧損本益比TTM

Myomo Inc

0.928
+0.027+3.05%

關於 Myomo Inc 公司

Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.

Myomo Inc簡介

公司代碼MYO
公司名稱Myomo Inc
上市日期Jun 12, 2017
CEOGudonis (Paul R)
員工數量184
證券類型Ordinary Share
年結日Jun 12
公司地址137 Portland Street
城市BOSTON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編02114
電話16179969058
網址https://myomo.com/
公司代碼MYO
上市日期Jun 12, 2017
CEOGudonis (Paul R)

Myomo Inc公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
481.86K
+1.57%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--
Mr. Thomas A. Crowley, Jr.
Mr. Thomas A. Crowley, Jr.
Independent Director
Independent Director
--
--
Mr. Micah J. Mitchell
Mr. Micah J. Mitchell
Chief Commercial Officer
Chief Commercial Officer
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Paul R. Gudonis
Mr. Paul R. Gudonis
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.25M
-0.79%
Mr. Thomas F. (Tom) Kirk, Ph.D.
Mr. Thomas F. (Tom) Kirk, Ph.D.
Lead Independent Director
Lead Independent Director
481.86K
+1.57%
Mr. David A. Henry
Mr. David A. Henry
Chief Financial Officer
Chief Financial Officer
427.90K
+11.59%
Dr. Harry Kovelman, M.D.
Dr. Harry Kovelman, M.D.
Chief Medical Officer
Chief Medical Officer
140.62K
+45.75%
Ms. Heather C. Getz, CPA
Ms. Heather C. Getz, CPA
Independent Director
Independent Director
41.75K
+246.97%
Dr. Milton M. Morris, Ph.D.
Dr. Milton M. Morris, Ph.D.
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 10月6日 週一
單位: USD更新時間: 10月6日 週一
FY2025Q2
FY2025Q1
業務USD
名稱
營收
佔比
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Direct to patient
7.42M
76.88%
Clinical/Medical providers
2.23M
23.12%

股東統計

更新時間: 11月17日 週一
更新時間: 11月17日 週一
持股股東
股東類型
持股股東
持股股東
佔比
Rosalind Advisors, Inc.
9.86%
Herr Investment Group LLC
7.40%
Triple Gate Capital, LP
7.35%
BlackRock Institutional Trust Company, N.A.
3.89%
The Vanguard Group, Inc.
3.86%
其他
67.63%
持股股東
持股股東
佔比
Rosalind Advisors, Inc.
9.86%
Herr Investment Group LLC
7.40%
Triple Gate Capital, LP
7.35%
BlackRock Institutional Trust Company, N.A.
3.89%
The Vanguard Group, Inc.
3.86%
其他
67.63%
股東類型
持股股東
佔比
Hedge Fund
21.84%
Investment Advisor
18.48%
Individual Investor
7.33%
Investment Advisor/Hedge Fund
6.34%
Research Firm
3.44%
Pension Fund
0.12%
Bank and Trust
0.08%
其他
42.37%

機構持股

更新時間: 10月1日 週三
更新時間: 10月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2025Q3
153
21.95M
58.07%
-1.84M
2025Q2
131
25.59M
71.13%
+1.42M
2025Q1
128
23.88M
66.62%
+977.96K
2024Q4
112
23.29M
69.71%
+5.81M
2024Q3
85
19.54M
71.85%
+1.13M
2024Q2
79
18.43M
69.76%
+448.58K
2024Q1
77
16.43M
64.97%
-1.27M
2023Q4
72
14.80M
62.04%
-346.58K
2023Q3
64
15.22M
79.76%
+6.49M
2023Q2
62
8.10M
62.40%
+2.44M
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Rosalind Advisors, Inc.
3.60M
9.51%
+892.13K
+33.00%
Jun 30, 2025
Herr Investment Group LLC
2.85M
7.53%
+1.20M
+72.93%
Jun 30, 2024
Triple Gate Capital, LP
2.83M
7.47%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
1.51M
4%
+1.40M
+1213.08%
Jun 30, 2025
The Vanguard Group, Inc.
1.49M
3.94%
+226.35K
+17.94%
Jun 30, 2025
Gudonis (Paul R)
1.25M
3.3%
-10.00K
-0.79%
Sep 09, 2025
Goldman Sachs & Company, Inc.
367.08K
0.97%
+201.64K
+121.88%
Jun 30, 2025
Geode Capital Management, L.L.C.
669.28K
1.77%
+412.63K
+160.78%
Jun 30, 2025
Renaissance Technologies LLC
541.40K
1.43%
+448.11K
+480.28%
Jun 30, 2025
Soleus Capital Management, L.P.
704.27K
1.86%
--
--
Jun 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0.01%
ProShares Hedge Replication ETF
0%
iShares Russell 2000 ETF
0%
iShares Russell 2000 Growth ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Micro-Cap ETF
佔比0.01%
ProShares Hedge Replication ETF
佔比0%
iShares Russell 2000 ETF
佔比0%
iShares Russell 2000 Growth ETF
佔比0%
Global X Russell 2000 ETF
佔比0%
Proshares Ultra Russell 2000
佔比0%
ProShares UltraPro Russell2000
佔比0%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據

常見問題

Myomo Inc的前五大股東是誰?

Myomo Inc的前五大股東如下:
Rosalind Advisors, Inc.
持有股份:3.60M
佔總股份比例:9.51%。
Herr Investment Group LLC
持有股份:2.85M
佔總股份比例:7.53%。
Triple Gate Capital, LP
持有股份:2.83M
佔總股份比例:7.47%。
BlackRock Institutional Trust Company, N.A.
持有股份:1.51M
佔總股份比例:4.00%。
The Vanguard Group, Inc.
持有股份:1.49M
佔總股份比例:3.94%。

Myomo Inc的前三大股東類型是什麼?

Myomo Inc 的前三大股東類型分別是:
Rosalind Advisors, Inc.
Herr Investment Group LLC
Triple Gate Capital, LP

有多少機構持有Myomo Inc(MYO)的股份?

截至2025Q3,共有153家機構持有Myomo Inc的股份,合計持有的股份價值約為21.95M,占公司總股份的58.07% 。與2025Q2相比,機構持股有所增加,增幅為-13.06%。

哪個業務部門對Myomo Inc的收入貢獻最大?

在FY2025Q2,Direct to patient業務部門對Myomo Inc的收入貢獻最大,創收7.42M,占總收入的76.88% 。
KeyAI